The Michael J. Fox Foundation's work as the largest nonprofit funder of Parkinson's research puts us at the nexus of activity in the field. The papers in this section illustrate our organizational point of view - informed by the perspectives of our staff, Parkinson's patients, and leading PD researchers from all over the world - on some of the research areas we are prioritizing to help drive development of better treatments and a cure.
Alpha-synuclein: Unlocking the Secrets of a Protein Implicated in Parkinson's Pathology
Cell Replacement Therapy: Restoring Function by Replacing Dead and Diseased Cells with Healthy Ones
Trophic Factors: Specialized Proteins that Nurture and Protect Neurons
